Literature DB >> 24619432

ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010.

C Moutou1, V Goossens, E Coonen, M De Rycke, G Kokkali, P Renwick, S B SenGupta, K Vesela, J Traeger-Synodinos.   

Abstract

STUDY QUESTION: How do data in the 12th annual data collection (Data XII) of the European Society of Human Reproduction and Embryology Preimplantation Genetic Diagnosis (PGD) Consortium compare with the cumulative data for collections I-XI? SUMMARY ANSWER: Since the beginning of the data collections, there has been a steady increase in the number of cycles, pregnancies and babies reported annually. WHAT IS KNOWN ALREADY: The PGD Consortium has collected, analysed and published 11 previous data sets since 1997. STUDY DESIGN, SIZE, DURATION: Data were collected from each participating centre using a pre-designed FileMaker Pro database (versions 5-10). Separate FileMaker Pro files were used for the cycles, pregnancies and baby records. The study documented cycles performed during the calendar year 2009 and follow-up of the pregnancies and babies born which resulted from these cycles (until October 2010). PARTICIPANTS/MATERIALS, SETTING,
METHODS: Data were submitted by 60 centres (full PGD Consortium members), and the blank files were distributed to each PGD Consortium member centre at the end of 2008. The submitted data were thoroughly analysed to identify incomplete data entries and corrections were requested from the participating centres. Records remaining with incomplete data were excluded from the calculations. Corrections, tables and calculations were made by expert co-authors. MAIN RESULTS AND THE ROLE OF CHANCE: For data collection XII, 60 centres reported data for 6160 cycles with oocyte retrieval (OR), along with details of the follow-up on 1607 pregnancies and 1238 babies born. A total of 870 OR were reported for chromosomal abnormalities, 113 OR for sexing for X-linked diseases, 1597 OR for monogenic diseases, 3551 OR for preimplantation genetic screening and 29 OR for social sexing. LIMITATIONS, REASONS FOR CAUTION: These data cannot include every PGD cycle performed annually, and only indicate the trends in PGD worldwide. WIDER IMPLICATION OF THE
FINDINGS: The annual data collections provide an extremely valuable resource for data mining and for following trends in PGD practice. STUDY FUNDING/COMPETING INTEREST(S): None.

Entities:  

Keywords:  ESHRE PGD consortium; PCR; PGD; fluorescence in situ hybridization; preimplantation genetic screening

Mesh:

Year:  2014        PMID: 24619432     DOI: 10.1093/humrep/deu012

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

Review 1.  Preimplantation genetic diagnosis/screening by comprehensive molecular testing.

Authors:  Hiroki Kurahashi; Takema Kato; Jun Miyazaki; Haruki Nishizawa; Eiji Nishio; Hiroshi Furukawa; Hironori Miyamura; Mayuko Ito; Toshiaki Endo; Yuya Ouchi; Hidehito Inagaki; Takuma Fujii
Journal:  Reprod Med Biol       Date:  2015-07-14

Review 2.  Preimplantation genetic diagnosis: an update on current technologies and ethical considerations.

Authors:  Kou Sueoka
Journal:  Reprod Med Biol       Date:  2015-11-14

3.  Microwells support high-resolution time-lapse imaging and development of preimplanted mouse embryos.

Authors:  Yu-Hsiang Chung; Yi-Hsing Hsiao; Wei-Lun Kao; Chia-Hsien Hsu; Da-Jeng Yao; Chihchen Chen
Journal:  Biomicrofluidics       Date:  2015-04-28       Impact factor: 2.800

4.  Discrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts.

Authors:  Ashley W Tiegs; Brooke Hodes-Wertz; David H McCulloh; Santiago Munné; James A Grifo
Journal:  J Assist Reprod Genet       Date:  2016-03-17       Impact factor: 3.357

5.  Medical genetics and genomic medicine in Greece: achievements and challenges.

Authors:  Irini Manoli; Helen Fryssira
Journal:  Mol Genet Genomic Med       Date:  2015-09-15       Impact factor: 2.183

6.  Current status of preimplantation genetic diagnosis in Japan.

Authors:  Kenji Sato; Kou Sueoka; Kotaro Iino; Hiroshi Senba; Mariko Suzuki; Yuki Mizuguchi; Yoko Izumi; Suguru Sato; Akira Nakabayashi; Mamoru Tanaka
Journal:  Bioinformation       Date:  2015-05-28

7.  The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus.

Authors:  Anne Girardet; Victoria Viart; Stéphanie Plaza; Gemma Daina; Martine De Rycke; Marie Des Georges; Francesco Fiorentino; Gary Harton; Aliya Ishmukhametova; Joaquima Navarro; Caroline Raynal; Pamela Renwick; Florielle Saguet; Martin Schwarz; Sioban SenGupta; Maria Tzetis; Anne-Françoise Roux; Mireille Claustres
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

8.  Spinocerebellar Ataxia Patient Perceptions Regarding Reproductive Options.

Authors:  Suzanne Cahn; Ami Rosen; George Wilmot
Journal:  Mov Disord Clin Pract       Date:  2019-11-25

9.  Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS.

Authors:  Elena E Zakharova; Victoria V Zaletova; Alexander S Krivokharchenko
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

Review 10.  The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis.

Authors:  Danilo Cimadomo; Antonio Capalbo; Filippo Maria Ubaldi; Catello Scarica; Antonio Palagiano; Rita Canipari; Laura Rienzi
Journal:  Biomed Res Int       Date:  2016-01-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.